Private equity GPs focus on value creation in their existing portfolios, with add-ons increasingly becoming a key ingredient in the private equity playbook.
The median hold period at exit continues to stretch longer, and the proportion of add-on acquisitions as a percentage of total investment activity reached 75%.
Strategic capital solutions are facilitating mid-hold value creation efforts that were not always available in the past.
These solutions seek to facilitate M&A or organic growth initiatives, cross-fund investments, shareholder consolidation, or other similar initiatives.
Mid-hold strategies help GPs capitalize on the work they’ve already put into their portfolio companies to drive further equity value in the business.
ASC’s specific mandate is centered on minority, non-control investments to facilitate predictable value creation within portfolios.
Mid-hold equity strategies provide another tool that allows sponsors to drive long-term growth and draw on private equity’s role as a provider of patient capital.
Valuations remain historically high; sponsors aren’t generally counting on multiple expansion unless they’re able to drive top- and bottom-line growth.
Mid-hold equity solutions are a way to meet the needs of today’s sponsors in looking to drive long-term value.
The growth of the segment is untethered to the current economic and market backdrop.